tiprankstipranks
Neovacs SA (DE:0LW)
:0LW
Germany Market

Neovacs SA (0LW) Income Statement

Compare
0 Followers

Neovacs SA Income Statement

Last quarter (Q2 2024), Neovacs SA's total revenue was €250.26K, an increase of 400.53% from the same quarter last year. In Q2, Neovacs SA's net income was €-30.99M. See Neovacs SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 533.41K€ 1.11K€ 22.54K€ 29.78K€ 95.15K
Gross Profit
€ 29.31K€ -3.43M€ -3.52M€ -1.79M€ 38.95K
Operating Expenses
€ 6.94M€ 2.99M€ 4.32M€ 1.70M€ 8.21M
Depreciation and Amortization
€ 163.91K€ 151.29K€ 99.37K€ 55.18K€ 56.21K
EBITDA
€ -8.45M€ -3.61M€ -10.38M€ -4.63M€ -9.14M
Operating Income
€ -6.91M€ -6.43M€ -7.84M€ -3.49M€ -8.27M
Other Income/Expenses
€ -2.71M€ 2.10M€ -4.64M€ -3.19M€ -1.03M
Pretax Income
€ -9.62M€ -4.35M€ -12.48M€ -6.68M€ -9.30M
Net Income
€ -8.74M€ -3.55M€ -11.84M€ -6.14M€ -7.55M
Per Share Metrics
€ ―€ ―€ ―€ ―€ ―
Basic EPS
€ -24.86€ -117.60€ -47.57K€ -729.37K€ -3.83M
Diluted EPS
€ -24.86€ -117.60€ -47.57K€ -729.37K€ -3.83M
Weighted Average Shares Outstanding
351.68K 30.18K---
Weighted Average Shares Outstanding (Diluted)
351.68K 30.18K---
Currency in EUR

Neovacs SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis